FDA Approval and Drug Market Collaborations: A Health Sector Update
Published on: March 9, 2026, 2:29 a.m. | Source: Devdiscourse
Recent health updates highlight the FDA's approval of Lantheus' new prostate cancer imaging agent to enhance production capacity. Additionally, Novo Nordisk and Hims & Hers Health have resolved their dispute, deciding to collaborate on selling obesity drugs, leading to a significant increase in Hims' share value.
